口服Jak3向药物对COVID患者的粘膜影响
Narendra Kumar1, Daniel Segovia2, Priyam Kumar3
1ILR-College of Pharmacy, Texas A&M University Health Science Center, Kingsville, TX, USA. narendra08@tamu.edu.
Molecular medicine (Cambridge, Mass.)
|May 23, 2025
概括
简氏激酶3 (JAK3) 抑制剂在治疗严重的COVID-19炎症方面表现有前途. 然而,它们的免疫抑制作用需要仔细选择和监测患者,以减轻二次感染的风险并优化治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 病毒学 病毒学
背景情况:
- 简氏激酶3 (JAK3) 对于免疫信号和炎症反应至关重要.
- 失调的JAK3激活与SARS-CoV-2感染中的严重炎症和呼吸系统问题有关.
- 作为COVID-19的治疗策略,JAK抑制剂正在被探索.
研究的目的:
- 审查JAK3在免疫和上皮细胞中的作用.
- 检查口服JAK3抑制剂在COVID-19和其他疾病中的不良影响.
- 讨论优化JAK抑制剂治疗的替代策略.
主要方法:
- 关于JAK3在免疫和炎症中的作用的文献综述.
- 分析口服JAK3抑制剂的不良影响.
- 探索替代治疗方法的探索.
主要成果:
- 在免疫和上皮细胞功能中,JAK3起着关键作用.
- 口服JAK3抑制剂携带免疫抑制和二次感染的风险.
- 目前的策略需要仔细选择和监测患者.
结论:
- 抑制JAK3是一种潜在的治疗COVID-19相关炎症.
- 平衡有效性与免疫抑制风险至关重要.
- 需要采用替代策略来改善安全性和结果.
相关概念视频
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
471
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
471
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
503
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
503
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
401
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
401


